Easocare vs GenomeUp: Revenue, Funding & Team Size Compared
Easocare generates $223.1K in revenue; GenomeUp generates $229.9K. GenomeUp and Easocare are close to the same size by revenue. The table below compares Easocare and GenomeUp on funding, valuation, customers, team size and headquarters — every figure GetLatka has verified for each company.
| Company |  EasocareThis company |  GenomeUp |
|---|---|---|
| Revenue | $223.1K | $229.9K |
| Valuation | $1.8M | Not disclosed |
| Funding raised | Not disclosed | $280.5K |
| Team size | 1 | 31 |
| Founded | 2019 | 2017 |
| HQ | Mumbai, India | Rome, Italy |
Want the full dataset? GetLatka tracks revenue, funding and team history for thousands of SaaS companies, with charts, growth rates and founder interviews.
Easocare at a glance
Easocare generates $223.1K in revenue with 1 employees, headquartered in Mumbai, India.
- Revenue
- $223.1K
- Valuation
- $1.8M
- Team size
- 1
- Founded
- 2019
Easocare is a SaaS platform which enables retail medical stores in India to go online by empowering them with digital tools
GenomeUp at a glance
GenomeUp generates $229.9K in revenue with 31 employees, headquartered in Rome, Italy.
- Revenue
- $229.9K
- Funding
- $280.5K
- Team size
- 31
- Founded
- 2017
GenomeUp is an AI platform for enabling doctors and clinical institutions to diagnose and treat rare genetic diseases in less than 24 hours.
Other Easocare alternatives
Easocare competes with more than the companies on this page. Browse the full alternative lists to compare revenue, funding and team size across the category.
Easocare vs GenomeUp: frequently asked questions
Is Easocare or GenomeUp bigger?
GenomeUp is the bigger company by revenue, at $229.9K against $223.1K for Easocare.
How much revenue does Easocare make?
Easocare generates $223.1K in annual revenue with a team of 1.
How much revenue does GenomeUp make?
GenomeUp generates $229.9K in annual revenue with a team of 31.
How much funding has GenomeUp raised?
GenomeUp has raised $280.5K in total funding since it was founded in 2017.